• News

"Lebrikizumab Clears Eczema Skin Rapidly, Safely" - Kevin Kunzmann

  • HCP Live
  • New York, NY
  • (March 04, 2020)

Novel monoclonal antibody lebrikizumab was shown to significantly benefit adults with moderate to severe atopic dermatitis (eczema) in new phase 2b data evidencing the interleukin 13 (IL-13)-targeting therapy.

Learn more